Brain choline acetyltransferase and mental function in Alzheimer disease.
OBJECTIVE
To determine whether higher brain levels of choline acetyltransferase (ChAT) are associated with improved neuropsychological function in patients with Alzheimer disease (AD).


METHODS
Case series with single-blind post hoc analysis of biopsy specimens.


METHODS
Urban hospital and medical school.


METHODS
A consecutive sample of 8 patients with AD undergoing brain biopsy and surgical implantation of intraventricular pumps for administration of potential chemotherapeutic agents.


METHODS
Brain biopsy, surgical implantation of intraventricular pumps, and, in 1 patient, ventriculoperitoneal shunt placement.


METHODS
All patients underwent neuropsychological testing no more than 2 weeks before surgical biopsy. Levels of ChAT were determined in fresh brain tissue from biopsy samples.


RESULTS
Significant positive correlations were found between ChAT levels and 2 neuropsychological test scores, Mini-Mental State Examination and the Logical Memory subtest of the Wechsler Memory Scale.


CONCLUSIONS
Degeneration of the cholinergic system in vivo correlates with decreasing cognitive function in patients with AD.
Baskin
D S
DS
Neurosurgery Section, Department of Surgery, Veterans Affairs Medical Center, Houston, Texas, USA. dbaskin@tmh.tmc.edu
Browning
J L
JL
Pirozzolo
F J
FJ
Korporaal
S
S
Baskin
J A
JA
Appel
S H
SH
D000368:Aged; D000544:Alzheimer Disease / Q000201:enzymology* / Q000523:psychology; D001706:Biopsy / Q000379:methods; D001921:Brain / Q000201:enzymology* / Q000601:surgery; D002795:Choline O-Acetyltransferase / Q000032:analysis*; D005260:Female; D006801:Humans; D008297:Male; D009483:Neuropsychological Tests
D002795:Choline O-Acetyltransferase